The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.
Radar 88 (high attention) · dilution pressure elevated · listing risk high · governance risk high · runway 51.4 mo · strongest signal: Departure cluster (Sep 14, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (negative equity) coexists with live selling machinery (shelf effective). Base case is a discounted raise; the question is when, not if.
Listing is at risk and the usual cures are constrained. Next thing to watch: a reverse-split proxy, a hearings-panel 8-K, or a Form 25. Exchange deficiency plus a structural reason cure is hard (sub-$5M float, negative equity, no cash, or a reverse split already used). Under Nasdaq's 2026 rules (one reverse split per 12 months; $5M MVLS floor with no cure period from Sept 2026) the usual escape hatches are narrower.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 80 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Sep 14, 2026 | ▼ Departure cluster | 3 Item 5.02 8-Ks in 90 days (latest 2026-09-14) filing | 60 |
| Sep 14, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-99.1) filed 2026-09-14 filing | 34 |
| Sep 14, 2026 | · Officer/director change | 8-K Item 5.02 filed 2026-09-14 (accepted 16:30 ET) filing | 22 |
| Sep 4, 2026 | ▼ Exchange deficiency notice | 8-K Item 3.01 filed 2026-09-04 (accepted 08:30 ET) filing | 55 |
| Sep 4, 2026 | ▼ Equity deficiency | “stockholders equity deficiency” language in 8-K (8-K) filed 2026-09-04 filing | 52 |
| Sep 4, 2026 | ▼ Delisting language | “delisting notice” language in 8-K (8-K) filed 2026-09-04 filing | 46 |
| Aug 27, 2026 | · Officer/director change | 8-K Item 5.02 filed 2026-08-27 (accepted 16:30 ET) filing | 22 |
| Aug 25, 2026 | ▼ Reverse split | “reverse split” language in DEF 14A (DEF 14A) filed 2026-08-25 filing | 29 |
| Aug 24, 2026 | ▼ Shelf effective | EFFECT notice 2026-08-24 filing | 21 |
| Jun 30, 2026 | ▼ Negative equity | Stockholders' equity $-35,324,000 as of 2026-06-30 filing | 31 |
AUID authID Inc. · SOBR SOBR Safe, Inc. · SDST Stardust Power Inc. · ADIL ADIAL PHARMACEUTICALS, INC. · GOVX GeoVax Labs, Inc. · MYSZ My Size, Inc. · screener →